Phase Ia Clinical Study of HDM1005 Injection

Clinical trial NCT06640647 · COMPLETED

Trial details

NCT number: NCT06640647
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity and Overweight

Start date: 2024-03-19
Primary completion: 2024-08-06
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.